Video

Eleanor Perfetto, PhD, MS, Describes the Importance of Comparative Effectiveness Research (CER) and the CER Collaborative Initiative

Eleanor Perfetto, PhD, MS, professor, pharmaceutical health services research, School of Pharmacy, University of Maryland, says that incorporating comparative effectiveness research (CER) into pharmacy curriculums is important for the next generation of pharmacists.

Eleanor Perfetto, PhD, MS, professor, pharmaceutical health services research, School of Pharmacy, University of Maryland, says that incorporating comparative effectiveness research (CER) into pharmacy curriculums is important for the next generation of pharmacists.

Understanding comparative effectiveness is essential for literature competency and evaluating research studies. A rigorous program, such as the one offered at the University of Maryland, will help students avoid learning “on the fly” as practitioners, and help them make evidence-based decisions.

Dr Perfetto also discusses the CER Collaborative Initiative. The group is comprised of researchers from 3 organizations including the Academy of Managed Care Pharmacy, International Society for Pharmacoeconomics and Outcomes Research, and the National Pharmaceutical Council. The tools and resources they develop help practitioners to appropriately utilize evidence-based research from studies like those that appear in AJMC.

Related Videos
Screenshot of an interview with Adam Colborn, JD
Screenshot of Stephanie Hsia, PharmD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo